top of page

NoQuil: Flavorless Cold Medicine for Kids

DN.webp

About

Project Overview

As part of Babson College's signature BETA-X Program, our team developed a new venture concept for P&G based on real-world market challenges. The project spanned two academic phases, each integrating core MBA coursework.

​

We identified a major pain point: children’s refusal to take medication due to taste, which often leads to stress for caregivers. Our solution, NoQuil, is a flavorless, easy-to-administer fever relief medicine for kids aged 2–12.

 

We applied interdisciplinary frameworks across strategy, finance, operations, marketing, and entrepreneurship to validate, pitch, and forecast this venture.

8b38482a-d086-4e12-af30-ceeaa6e3f12f.JPG

Project Overview

  • Identify and validate a pressing consumer problem within P&G’s existing business scope

  • Design a market-viable product addressing pain points for parents and pediatricians

  • Build a scalable business model, including go-to-market strategy, supply chain, and financial projections

  • Integrate classroom learning across MBA courses into real-world startup execution

Approach & Structure

Phase 1:

Foundational Strategy & Organizational Design

  • Problem definition: Taste aversion in kids' medication, even with the artificial flavors

  • Persona development: Working parents with children under 12

  • Customer Value Proposition (CVP): NoQuil enables stress-free medication with taste-masking technology

  • Positioning: First-mover in the flavorless Over-the-Counter (OTC) fever medicine category

  • Organizational values: Trust, accountability, and parent empathy

  • Midterm pitch: Included need validation, competitor matrix, and early financial forecast

Phase 2:

Operational Execution & Financial Modeling

  • Market sizing: ~$9.8B U.S. acetaminophen market; ~$8.5M Year 1 obtainable market

  • Go-to-market strategy:

    • Soft launch in New England (CVS, Walgreens)

    • Expansion via pediatrician endorsements and retail shelf partnerships

  • Cost structure:

    • $3.65 COGS per bottle

    • 51% gross margin

    • Payback in 15 months

  • Revenue model: Retail-driven with D2C channel expansion in Year 2

  • Global scaling strategy: Europe & Asia in Years 4–5

Skills

  • Market Research & Customer Validation

  • Product-Market Fit & CVP Design

  • Business Modeling (Top-down & Bottom-up)

  • Competitive Analysis (e.g., Porter’s Five Forces, Value Chain)

  • Financial Forecasting & Break-even Analysis

  • Pitching & Storytelling

  • Cross-functional Collaboration

Role

  • Even with a great product idea, success depends on detailed consumer insight, financial rigor, and go-to-market discipline.

  • Scalability and simplicity are critical when addressing underserved consumer pain points.

  • Taste-masking as an innovation lever can build first-mover advantage in highly commoditized healthcare categories.

I was actively involved across both phases. I contributed to problem framing, helped design the competitive positioning, and supported financial assumptions and scalability modeling for our launch plan. I also collaborated closely on crafting our midterm and final pitch decks.

Key Takeaways

Key Takeaways

Role

  • Even with a great product idea, success depends on detailed consumer insight, financial rigor, and go-to-market discipline.

  • Scalability and simplicity are critical when addressing underserved consumer pain points.

  • Taste-masking as an innovation lever can build first-mover advantage in highly commoditized healthcare categories.

I was actively involved across both phases. I contributed to problem framing, helped design the competitive positioning, and supported financial assumptions and scalability modeling for our launch plan. I also collaborated closely on crafting our midterm and final pitch decks.

Appendix

Final Presentation Deck

bottom of page